標準危険群に対する代謝拮抗剤治療の適応と限界, 晩期障害軽減の試み 小児癌・白血病研究グループ
新 渡辺, 正仁 鶴澤 · 日本小児血液学会雑誌 · 2004
Cited by 0 works. doi:10.11412/jjph1987.18.189
Authors
References
- Anthracycline-Induced Cardiotoxicity
- Prognostic Importance of 6-Mercaptopurine Dose Intensity in Acute Lymphoblastic Leukemia
- Early Intensification of Intrathecal Chemotherapy Virtually Eliminates Central Nervous System Relapse in Children With Acute Lymphoblastic Leukemia
- Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation
- Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital.
- Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins
- Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment
- Dose-dependant kinetics of oral 6-mercapopurine in children with leukemia